| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1000157956 |
| P356 | DOI | 10.1016/J.NURT.2006.10.003 |
| P698 | PubMed publication ID | 17199018 |
| P5875 | ResearchGate publication ID | 6601886 |
| P50 | author | Alan B. Ettinger | Q112421885 |
| P2093 | author name string | Charles E Argoff | |
| P2860 | cites work | Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder | Q21260296 |
| Topiramate for acute affective episodes in bipolar disorder | Q24244960 | ||
| Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial | Q29029237 | ||
| Brain Serotonin1A Receptor Binding Measured by Positron Emission Tomography With [11C]WAY-100635 | Q29999635 | ||
| PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy | Q30775960 | ||
| Placebo-controlled study of divalproex sodium for agitation in dementia | Q31825522 | ||
| A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal | Q46921168 | ||
| Disregulation of hypothalamic-pituitary-adrenal axis in the mentally retarded | Q48472314 | ||
| The effect of valproic acid on 5-hydroxytryptamine and 5-hydroxyindoleacetic acid concentration in hippocampal dialysates in vivo | Q48686963 | ||
| Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats: dose response relationships | Q48707882 | ||
| Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes | Q48766109 | ||
| Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial | Q48779182 | ||
| Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy. | Q51098970 | ||
| The analgesic effect of tocainide in trigeminal neuralgia. | Q51798511 | ||
| Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial. | Q51947305 | ||
| Gabapentin: long-term antianxiety and hypnotic effects in psychiatric patients with comorbid anxiety-related disorders. | Q51995028 | ||
| Pimozide therapy for trigeminal neuralgia. | Q54105655 | ||
| Acute psychotic disorders induced by topiramate: report of two cases | Q57086623 | ||
| Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial | Q57984131 | ||
| Topiramate in Treatment of Patients With Chronic Low Back Pain | Q60634424 | ||
| Two cases of nonconvulsive status epilepticus in association with tiagabine therapy | Q62869102 | ||
| Tizanidine in the management of trigeminal neuralgia | Q68907716 | ||
| A four year double-blind study of tegretol in facial pain | Q69884656 | ||
| Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol�): Double blind crossover trial | Q69894207 | ||
| Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve | Q70910954 | ||
| Carbamazepine in manic-depressive illness: a new treatment | Q71229902 | ||
| Panic disorder: treatment with valproate | Q72152270 | ||
| A case report of reduction in alcohol craving and protection against alcohol withdrawal by gabapentin | Q73082254 | ||
| Phenytoin as an antimanic anticonvulsant: a controlled study | Q73501981 | ||
| Topiramate as add-on treatment for patients with bipolar mania | Q73634791 | ||
| Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder | Q77720351 | ||
| Efficacy of gabapentin in treating chronic phantom limb and residual limb pain | Q83062380 | ||
| Lamotrigine for central poststroke pain: a randomized controlled trial. | Q31845404 | ||
| Treatment of social phobia with gabapentin: a placebo-controlled study | Q33420919 | ||
| Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia | Q33629142 | ||
| 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double-blind, placebo controlled trial | Q33743755 | ||
| A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. | Q33844681 | ||
| Efficacy of gabapentin in migraine prophylaxis | Q33938297 | ||
| The rationale and use of topiramate for treating neuropathic pain | Q33963526 | ||
| Pharmacotherapy of trigeminal neuralgia | Q34110447 | ||
| Depression, IV: STAR*D treatment trial for depression | Q34174320 | ||
| Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design | Q34310720 | ||
| Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats | Q34479439 | ||
| Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. | Q34507312 | ||
| Open-label adjunctive topiramate in the treatment of bipolar disorders. | Q34509360 | ||
| Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders | Q34530012 | ||
| Antiepileptic drugs: indications other than epilepsy. | Q34549201 | ||
| Use of anticonvulsants for treatment of neuropathic pain | Q34832100 | ||
| Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate | Q34976043 | ||
| Effects of Topiramate on Aggressive, Self-Injurious, and Disruptive/Destructive Behaviors in the Intellectually Disabled: An Open-Label Retrospective Study | Q35547648 | ||
| Behavioural effects of the newer antiepileptic drugs: an update | Q35609738 | ||
| Topiramate in migraine prevention | Q36099519 | ||
| Antiepileptic drugs in mood-disordered patients | Q36169536 | ||
| Anticonvulsants in the treatment of bipolar mania | Q36407359 | ||
| Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial | Q39355231 | ||
| Topiramate in chronic lumbar radicular pain | Q39358373 | ||
| Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study | Q39362494 | ||
| Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial | Q39368431 | ||
| Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial | Q39377711 | ||
| Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression | Q39410022 | ||
| Tiagabine appears not to be efficacious in the treatment of acute mania | Q39434446 | ||
| Intravenous infusion of phenytoin relieves neuropathic pain: a randomized, double-blinded, placebo-controlled, crossover study | Q39435975 | ||
| Central post-stroke pain--a controlled trial of amitriptyline and carbamazepine | Q39529388 | ||
| Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials | Q40484484 | ||
| Phenytoin in the treatment of diabetic symmetrical polyneuropathy | Q40787813 | ||
| Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy | Q40979712 | ||
| Clinical studies of valproate for migraine prophylaxis | Q41460262 | ||
| Benzodiazepine withdrawal delirium with catatonic features. Occurrence in patients with partial seizure disorders | Q42198082 | ||
| Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats | Q42454283 | ||
| A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. | Q42613693 | ||
| A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group | Q42626284 | ||
| Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder | Q42627601 | ||
| A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes | Q42627987 | ||
| A preliminary open-label study of zonisamide treatment for bipolar depression in 10 patients | Q42647636 | ||
| A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. | Q42666732 | ||
| Tiagabine in treatment refractory bipolar disorder: a clinical case series. | Q42690598 | ||
| Carbamazepine in the treatment of neuralgia. Use of side effects | Q43425919 | ||
| Accelerated weight loss after treating refractory depression with fluoxetine plus topiramate: possible mechanisms of action? | Q43587334 | ||
| Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study | Q43787190 | ||
| Levetiracetam psychosis in children with epilepsy | Q43906073 | ||
| Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial. | Q43942064 | ||
| Lamotrigine in spinal cord injury pain: a randomized controlled trial | Q43969767 | ||
| Acute psychotic disorders induced by topiramate: report of two cases | Q44030672 | ||
| Sodium valproate in the treatment of aggressive behavior in patients with dementia--a randomized placebo controlled clinical trial | Q44060144 | ||
| Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study | Q44103185 | ||
| A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy | Q44129801 | ||
| Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design | Q44272770 | ||
| Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients. | Q44359601 | ||
| A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder | Q44403599 | ||
| Divalproex in the Treatment of Impulsive Aggression: Efficacy in Cluster B Personality Disorders | Q44407169 | ||
| Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial | Q44411545 | ||
| Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial | Q44438587 | ||
| Tolerability of topiramate in children and adolescents | Q44550131 | ||
| Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design | Q44559995 | ||
| Psychiatric adverse events during levetiracetam therapy | Q44578346 | ||
| A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events | Q44607327 | ||
| Prophylactic effect of phenytoin in bipolar disorder: a controlled study | Q44667923 | ||
| Gabapentin for the treatment of behavioural alterations in dementia: preliminary 15-month investigation. | Q44677248 | ||
| Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control. | Q44682260 | ||
| Worsening of psychosis after replacement of adjunctive valproate with topiramate in a schizophrenia patient. | Q44682266 | ||
| A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression. | Q44787822 | ||
| Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode | Q44801076 | ||
| Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. | Q44843017 | ||
| A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. | Q44877765 | ||
| Worsening of psychosis or topiramate-induced adverse event? | Q44879341 | ||
| Levetiracetam in bipolar spectrum disorders: first evidence of efficacy in an open, add- on study | Q44977887 | ||
| Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects | Q45057234 | ||
| An open-label study of levetiracetam for the treatment of social anxiety disorder | Q45058748 | ||
| Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study. | Q45156806 | ||
| Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial | Q45185821 | ||
| Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study | Q45195617 | ||
| A comparison of anticonvulsants in the treatment of impulsive aggression | Q45279949 | ||
| Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study. | Q45287382 | ||
| Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of BID versus TID dosing | Q45288098 | ||
| Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. | Q46377270 | ||
| Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial | Q46428489 | ||
| Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder | Q46448298 | ||
| Controlled double-blind trial of phenytoin vs. fluoxetine in major depressive disorder. | Q46487090 | ||
| Topiramate-induced psychosis | Q46628170 | ||
| Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam | Q46688430 | ||
| P433 | issue | 1 | |
| P921 | main subject | chronic pain | Q1088113 |
| P304 | page(s) | 75-83 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Neurotherapeutics | Q15716631 |
| P1476 | title | Use of antiepileptic drugs for nonepileptic conditions: psychiatric disorders and chronic pain | |
| P478 | volume | 4 |
| Q48152117 | A Novel Pregabalin Functionalized Salicylaldehyde Derivative Afforded Prospective Pain, Inflammation, and Pyrexia Alleviating Propensities. |
| Q38231316 | Adverse skeletal effects of drugs - beyond Glucocorticoids |
| Q43244748 | Analgesic activity of 3-mono-substituted derivatives of dihydrofuran-2-one in experimental rodent models of pain |
| Q48316817 | Anticonvulsant effect of sodium cyclamate and propylparaben on pentylenetetrazol-induced seizures in zebrafish. |
| Q37901704 | Antiepileptic drug therapy: does mechanism of action matter? |
| Q45814535 | Antiepileptic drug use in seven electronic health record databases in Europe: a methodologic comparison. |
| Q37029357 | Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy |
| Q48408052 | Are psychiatric disorders independent risk factors for new-onset epilepsy in older individuals? |
| Q93338160 | Association of the US Food and Drug Administration Antipsychotic Drug Boxed Warning With Medication Use and Health Outcomes in Elderly Patients With Dementia |
| Q44344739 | Changes in opioid and other analgesic use 1995-2010: repeated cross-sectional analysis of dispensed prescribing for a large geographical population in Scotland |
| Q35779591 | Characteristics of evoked potential multiple EEG recordings in patients with chronic pain by means of parallel factor analysis |
| Q37072369 | Chronic nonmalignant pain: a challenge for patients and clinicians |
| Q33610934 | Clinical outcomes and immune benefits of anti-epileptic drug therapy in HIV/AIDS. |
| Q86043671 | Combination of diacerhein and antiepileptic drugs after local peripheral, and oral administration in the rat formalin test |
| Q38907478 | Computational approaches for innovative antiepileptic drug discovery |
| Q36420453 | Concomitant medication of psychoses in a lifetime perspective |
| Q60711535 | Current and emerging therapies for migraine prevention and treatment |
| Q42794505 | Dose-response relationship analysis of pregabalin doses and their antinociceptive effects in hot-plate test in mice |
| Q48350926 | Effect of topiramate on choroidal thickness and anterior chamber parameters in the treatment of patients with migraine |
| Q39803558 | Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentin |
| Q33557870 | Evaluation of Medication-mediated Effects in Pharmacoepidemiology |
| Q47116750 | Exploring mechanochemistry to turn organic bio-relevant molecules into metal-organic frameworks: a short review. |
| Q33579584 | Forecasting drug utilization and expenditure in a metropolitan health region |
| Q60670852 | Gabapentin and Pregabalin for the Treatment of Anxiety Disorders |
| Q39323350 | Gabapentin as a potential option for treatment of sciatica |
| Q37836720 | Galanin, galanin receptors, and drug targets. |
| Q44014115 | Have antiepileptic drug prescription claims changed following the FDA suicidality warning? An evaluation in a state Medicaid program |
| Q48102202 | Intrahippocampal infusion of the Ih blocker ZD7288 slows evoked theta rhythm and produces anxiolytic-like effects in the elevated plus maze. |
| Q94591423 | Lacosamide intake during pregnancy increases the incidence of foetal malformations and symptoms associated with schizophrenia in the offspring of mice |
| Q39018798 | Mood Spectrum Disorders and Perception of Pain |
| Q48629503 | Multifactorial etiology of interictal behavior in frontal and temporal lobe epilepsy. |
| Q47672772 | Nociceptive blink reflex habituation biofeedback in migraine. |
| Q30577314 | Novel, broad-spectrum anticonvulsants containing a sulfamide group: pharmacological properties of (S)-N-[(6-chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide (JNJ-26489112) |
| Q46789614 | Oxcarbazepine may induce psychotic symptoms in Parkinson's disease |
| Q45988509 | Possible epileptic origin of symptoms in a case exemplifying the sleeper kind of 'limbic psychotic trigger reaction'. |
| Q37987988 | Prevalence, clinical features and potential therapies for fibromyalgia in primary headaches |
| Q42952917 | Psychiatric comorbidity in patients with epilepsy: a population-based study |
| Q41920185 | Psychosomatic factors in pruritus |
| Q54256432 | Reversible Thrombocytopenia after Gabapentin in an HIV-Positive Patient. |
| Q24186448 | Sodium channel blockers for neuroprotection in multiple sclerosis |
| Q24200461 | Sodium channel blockers for neuroprotection in multiple sclerosis |
| Q42103236 | Stability of Extemporaneously Compounded Levetiracetam in Glass and Plastic Bottles and Plastic Syringes. |
| Q41788498 | Stability of levetiracetam in extemporaneously compounded suspensions |
| Q33523160 | Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system |
| Q39244593 | Synergistic interaction of pregabalin with the synthetic cannabinoid WIN 55,212-2 mesylate in the hot-plate test in mice: an isobolographic analysis. |
| Q48216780 | Synthesis and pharmacological properties of new GABA uptake inhibitors. |
| Q28744504 | The effectiveness of anticonvulsants in psychiatric disorders |
| Q34706201 | Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites |
| Q37714086 | Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders. |
| Q40116422 | Zonisamide prevents olanzapine-associated hyperphagia, weight gain, and elevated blood glucose in rats |
Search more.